These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 12161029)

  • 21. Experimental autoimmune uveoretinitis (EAU) in rats: abrogation of resistance to the induction and augmentation of the inflammation by pertussis toxin.
    Suzuki I; Takahashi S; Fujii Y; Fuyama S; Arai S
    Jpn J Ophthalmol; 1989; 33(1):27-35. PubMed ID: 2786590
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evidence for selective accumulation of V beta 8+ T lymphocytes in experimental autoimmune uveoretinitis induced with two different retinal antigens.
    Egwuagu CE; Mahdi RM; Nussenblatt RB; Gery I; Caspi RR
    J Immunol; 1993 Aug; 151(3):1627-36. PubMed ID: 8393049
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevention of experimental autoimmune uveoretinitis by monoclonal antibody to interleukin-12.
    Yokoi H; Kato K; Kezuka T; Sakai J; Usui M; Yagita H; Okumura K
    Eur J Immunol; 1997 Mar; 27(3):641-6. PubMed ID: 9079803
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CCR5-deficient mice develop experimental autoimmune uveoretinitis in the context of a deviant effector response.
    Takeuchi A; Usui Y; Takeuchi M; Hattori T; Kezuka T; Suzuki J; Okunuki Y; Iwasaki T; Haino M; Matsushima K; Usui M
    Invest Ophthalmol Vis Sci; 2005 Oct; 46(10):3753-60. PubMed ID: 16186359
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The immunomodulator vasoactive intestinal peptide (VIP) does not affect experimental autoimmune uveitis (EAU) in B10.RIII mice.
    Chen J; Vistica B; Wiggert B; Chan CC; Gery I
    Ocul Immunol Inflamm; 2005 Feb; 13(1):13-7. PubMed ID: 15804764
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of experimental autoimmune uveoretinitis by anti-delta-like ligand 4 monoclonal antibody.
    Ishida W; Fukuda K; Sakamoto S; Koyama N; Koyanagi A; Yagita H; Fukushima A
    Invest Ophthalmol Vis Sci; 2011 Oct; 52(11):8224-30. PubMed ID: 21896864
    [TBL] [Abstract][Full Text] [Related]  

  • 27. T cell mechanisms in experimental autoimmune uveoretinitis: susceptibility is a function of the cytokine response profile.
    Caspi RR; Sun B; Agarwal RK; Silver PB; Rizzo LV; Chan CC; Wiggert B; Wilder RL
    Eye (Lond); 1997; 11 ( Pt 2)():209-12. PubMed ID: 9349414
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-inflammatory property of the cannabinoid receptor-2-selective agonist JWH-133 in a rodent model of autoimmune uveoretinitis.
    Xu H; Cheng CL; Chen M; Manivannan A; Cabay L; Pertwee RG; Coutts A; Forrester JV
    J Leukoc Biol; 2007 Sep; 82(3):532-41. PubMed ID: 17537989
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Disruption of CD40/CD40-ligand interactions in a retinal autoimmunity model results in protection without tolerance.
    Bagenstose LM; Agarwal RK; Silver PB; Harlan DM; Hoffmann SC; Kampen RL; Chan CC; Caspi RR
    J Immunol; 2005 Jul; 175(1):124-30. PubMed ID: 15972638
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Orally induced bystander suppression in experimental autoimmune uveoretinitis occurs only in the periphery and not in the eye.
    Wildner G; Thurau SR
    Eur J Immunol; 1995 May; 25(5):1292-7. PubMed ID: 7774632
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevention of experimental autoimmune uveoretinitis by vasoactive intestinal peptide.
    Keino H; Kezuka T; Takeuchi M; Yamakawa N; Hattori T; Usui M
    Arch Ophthalmol; 2004 Aug; 122(8):1179-84. PubMed ID: 15302659
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Uveoretinitis and pinealitis induced by immunization with interphotoreceptor retinoid-binding protein.
    Gery I; Wiggert B; Redmond TM; Kuwabara T; Crawford MA; Vistica BP; Chader GJ
    Invest Ophthalmol Vis Sci; 1986 Aug; 27(8):1296-300. PubMed ID: 3488297
    [TBL] [Abstract][Full Text] [Related]  

  • 33. T helper 1 and T helper 2 cells respond differentially to chemokines.
    Siveke JT; Hamann A
    J Immunol; 1998 Jan; 160(2):550-4. PubMed ID: 9551886
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Suppression of experimental autoimmune uveoretinitis by regulatory dendritic cells in mice.
    Usui Y; Takeuchi M; Hattori T; Okunuki Y; Nagasawa K; Kezuka T; Okumura K; Yagita H; Akiba H; Goto H
    Arch Ophthalmol; 2009 Apr; 127(4):514-9. PubMed ID: 19365033
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A new model of autoimmune disease. Experimental autoimmune uveoretinitis induced in mice with two different retinal antigens.
    Caspi RR; Roberge FG; Chan CC; Wiggert B; Chader GJ; Rozenszajn LA; Lando Z; Nussenblatt RB
    J Immunol; 1988 Mar; 140(5):1490-5. PubMed ID: 3346541
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IL-18 not required for IRBP peptide-induced EAU: studies in gene-deficient mice.
    Jiang HR; Wei X; Niedbala W; Lumsden L; Liew FY; Forrester JV
    Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):177-82. PubMed ID: 11133864
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Translational research with experimental autoimmune uveoretinitis (EAU)].
    Usui M
    Nippon Ganka Gakkai Zasshi; 2007 Mar; 111(3):137-58; discussion 159. PubMed ID: 17402560
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Establishment and characterization of a murine CD4+ T cell line and clone that induce experimental autoimmune uveoretinitis in B10.A mice.
    Rizzo LV; Silver P; Wiggert B; Hakim F; Gazzinelli RT; Chan CC; Caspi RR
    J Immunol; 1996 Feb; 156(4):1654-60. PubMed ID: 8568272
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Autoimmunity to a pathogenic retinal antigen begins as a balanced cytokine response that polarizes towards type 1 in a disease-susceptible and towards type 2 in a disease-resistant genotype.
    Sun B; Sun SH; Chan CC; Wiggert B; Caspi RR
    Int Immunol; 1999 Aug; 11(8):1307-12. PubMed ID: 10421788
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Leucine-Rich Repeat Kinase 2 (Lrrk2) Deficiency Diminishes the Development of Experimental Autoimmune Uveitis (EAU) and the Adaptive Immune Response.
    Wandu WS; Tan C; Ogbeifun O; Vistica BP; Shi G; Hinshaw SJ; Xie C; Chen X; Klinman DM; Cai H; Gery I
    PLoS One; 2015; 10(6):e0128906. PubMed ID: 26067490
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.